Araştırma Makalesi

Alzheimer hastalığında doublecortin-like kinaz-1 düzeyleri ve oksidan durumu

Cilt: 42 Sayı: 4 31 Aralık 2017
Savaş Güzel , Özlem Yıldız , Aysun Ünal , Ali Rıza Kızıler , Tevfik Gülyaşar , Eda Çelik Güzel , Çiğdem Fidan
PDF İndir
EN TR

Doublecortin-like kinase 1 levels and oxidant status in Alzheimer's disease

Abstract

Purpose: Alzheimer disease (AD) is a progressive neurodegenerative disease that affects the neurons in various parts of the central nervous system. Recently discovered protein Doublecort like kinase-1 (DCLK-1) is one of the microtubule-associated protein. Our goal is to investigate the relationship of the role of the DCLK-1 in AD disease and oxidative stress.

Material and Methods: The study included Alzheimer-disease-diagnosed 60 patients admitted to the clinic with memory disorders, and 30 healthy subjects. In the serum of patient and control group, DCLK-1, tau protein and zinc levels were measured. To assess the presence of oxidative stress, malondialdehyde (MDA), protein carbonyl group (PCG), protein thiol groups (PTG), glutathione (GSH) and catalase levels were detected. Dementia level was staged with Mini-Mental State Examination (MMSE) and Dementia Clinical Staging Scale (CDR). 

Results: Serum DCLK-1 and tau levels were determined significantly higher in AD compared to the control group). In the group with AD, levels of MDA, and PCG levels were significantly higher and GSH, catalase levels were determined significantly lower. DCLK-1 and MDA levels were determined significantly higher in the group with severe AD compared to the group with mild AD. In AD group, a positive correlation between DCLK-1 and, CDR and MDA; and negative correlation was found between MMSE and B12 vitamin 

Conclusions: The presence of a relation with increase in DCLK1 levels in AD and risk factors shows that it can be a new marker in assessing the disease. 

Keywords

DCLK-1,tau,Alzheimer's disease,zinc,oxidative stress

Kaynakça

  1. no.reference

Kaynak Göster

MLA
Güzel, Savaş, vd. “Doublecortin-like kinase 1 levels and oxidant status in Alzheimer’s disease”. Cukurova Medical Journal, c. 42, sy 4, Aralık 2017, ss. 687-93, doi:10.17826/cutf.325707.